The goal of this investigation was to retrospectively compare the recently proposed Prostate Imaging Reporting and Data System (PI-RADS) scale with the older Likert scale, using multiparametric MRI in ...
Survival impact of initial local therapy selection for men under 60 with high risk prostate cancer. Prostate cancer (PCa) in 696 hypogonadal men with and without long-term testosterone therapy (TTh): ...
Combining PSA density with prostate MRI findings improves the predictive performance of PI-RADS in men without a prior prostate cancer diagnosis. Combining PSA density (PSAD) with prostate magnetic ...
Upgrade and downgrade rates from targeted biopsy to radical prostatectomy were not significantly different between patients whose MRI examinations were clinically interpreted using PI-RADS Version ...
PI-RADS version 2.1 demonstrated improved detection of clinically significant prostate cancer in the transition zone. For detecting clinically significant prostate cancer (csPCa), prostate imaging ...
Prostate specific antigen testing as disease surveillance and monitoring five years after definitive therapy for localized prostate cancer. Relative risk of HTN and major cardiovascular events ...
Innovative technology performs automatic segmentation and lesion detection in prostate MRI scans to assist in PI-RADS scoring for prostate cancer management TEL AVIV, Israel & SAN JOSE, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results